All Type of News
Purchasing contract by Boramae hospital at dumping prices rumoured.
Amid impending massive price slash by the government on overall insurance drugs the pharmaceutical industry decided that any dumping bidding attempted by Boramae hospital should be definitely blockaded by all means in...
115 imported drugs additionally registered insurance price.
The Medical Insurance Price Evaluation Commission provided an additional registration chance of medical insurance reimbursement plan for local products July 12 and 13 and for imported drugs on July 14 and 15.
Acco...
KRPIA officially criticized insurance pricing policy on imported drugs.
The KRPIA took a press interview on July 16 at Plaza hotel and expressed their official position.
They announced with regard to the government insurance pricing policy of imported drugs, as saying "the government dis...
Domestic new drug No. 1, Sunpla inj. approved
The KFDA approved Sunpla inj., a platinum chelate complex anticancer drug, as the first new drug originated from Korea on July 13, which was developed by SK Pharmaceutical (President: Cho Min-ho) at 8.1 billion won of...
21 new drugs under clinical research.
Along with the first introduction of domestically developed new drug many interesting attentions are paid to the 21 candidates of new drugs in future, which are still under the clinical research stage and 2 ...
Significant business recovery sign seen in drug industry.
Once seriously ailing business activities in drug industry after the IMF economic crisis seem to turn up significantly from the first half of this year, showing 7.3% sales growth on average of the leading lo...
MOHW pressed National Assembly to pass revised bill for pharmaceutical affairs law.
The foreign multinational pharmaceutical corporations have complained to our government that their product information data for health registration submitted to the government used to be disclosed and exploited by oth...
Zuellig's plan for 5,000 customer direct deals on progress
KLS, a Korean legal business entity of Zuellig, seems to drive their drug distribution business plans from coming Sept., for which the KPA sensitively concerned and tried to prepare an appropriate action against the s...
Administrator Huh of KFDA reported major issues to National Assembly.
Dr. Huh, the administrator of the KFDA attended to the Health and Welfare Commission of the National Assembly and reported important issues to including the preventive measures against intoxication of food poisons and...
KPhTA asked for 6 month postponement of imported drug insurance price registration.
The Korea Pharmaceutical Trade Association (KPhTA) proposed to the MOHW for at least 6 month postponement of drug insurance price registration recently announced to implement from July 1 by the MOHW on account of the ...
